Lifevantage Corporation
LFVN
$4.65
-$0.03-0.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 210.05M | 228.88M | 228.53M | 222.35M | 212.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 210.05M | 228.88M | 228.53M | 222.35M | 212.15M |
| Cost of Revenue | 44.65M | 45.12M | 44.86M | 43.82M | 42.88M |
| Gross Profit | 165.40M | 183.76M | 183.67M | 178.53M | 169.27M |
| SG&A Expenses | 156.71M | 171.86M | 171.47M | 165.57M | 158.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 201.36M | 216.98M | 216.33M | 209.39M | 201.31M |
| Operating Income | 8.69M | 11.90M | 12.20M | 12.96M | 10.84M |
| Income Before Tax | 9.29M | 11.91M | 12.24M | 12.56M | 10.30M |
| Income Tax Expenses | 1.43M | 1.77M | 2.44M | 3.41M | 2.96M |
| Earnings from Continuing Operations | 7.86 | 10.13 | 9.81 | 9.15 | 7.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.86M | 10.13M | 9.81M | 9.15M | 7.34M |
| EBIT | 8.69M | 11.90M | 12.20M | 12.96M | 10.84M |
| EBITDA | 11.61M | 14.87M | 15.36M | 16.17M | 14.15M |
| EPS Basic | 0.64 | 0.82 | 0.80 | 0.75 | 0.60 |
| Normalized Basic EPS | 0.46 | 0.60 | 0.62 | 0.64 | 0.53 |
| EPS Diluted | 0.60 | 0.77 | 0.74 | 0.69 | 0.56 |
| Normalized Diluted EPS | 0.43 | 0.57 | 0.58 | 0.60 | 0.50 |
| Average Basic Shares Outstanding | 49.72M | 49.29M | 49.05M | 48.98M | 49.05M |
| Average Diluted Shares Outstanding | 52.12M | 52.55M | 52.43M | 52.17M | 51.85M |
| Dividend Per Share | 0.18 | 0.17 | 0.17 | 0.16 | 0.16 |
| Payout Ratio | 28.13% | 21.10% | 21.08% | 21.94% | 26.61% |